D

Ginkgo Bioworks Holdings
D

DNA

8.54000
USD
0.02
(0.18%)
مغلق
حجم التداول
22,391
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
499,862,230
أصول ذات صلة
AMGN
AMGN
-16.85
(-5.82%)
272.55 USD
BIIB
BIIB
-2.253
(-1.77%)
124.797 USD
C
CRSP
1.330
(3.01%)
45.570 USD
E
EDIT
-0.12000
(-5.38%)
2.11000 USD
GILD
GILD
-1.810
(-1.68%)
106.190 USD
N
NTLA
0.04500
(0.49%)
9.23500 USD
REGN
REGN
1.66
(0.33%)
511.36 USD
S
SGMO
-0.03440
(-7.41%)
0.43000 USD
VRTX
VRTX
2.63
(0.60%)
443.60 USD
المزيد
الأخبار المقالات

العنوان: Ginkgo Bioworks Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.